Barkibu vs Apple Watch
Side-by-side comparison of AI visibility scores, market position, and capabilities
A Coruña Spain pet telemedicine + AI insurance (Munich Re) across 7 European countries at €50M turnover with 75K+ insured pets; BAI trained on 800K consultations with 80% retention competing with Agria for European pet health platform.
About
Barkibu is an A Coruña, Spain-based pet health and insurance platform — operating across seven European countries (Spain, Germany, France, Italy, Portugal, Greece, and Finland) with approximately €50 million in annual turnover and 75,000+ insured animals — providing pet owners with AI-powered veterinary triage, telemedicine consultations with licensed veterinarians, and comprehensive pet insurance underwritten by Munich Re that processes most claims automatically within minutes through proprietary AI. Barkibu's BAI (Barkibu Artificial Intelligence), trained on over 800,000 veterinary consultations, provides 24/7 symptom assessment for dogs and cats. The company projects reaching 125,000 insured pets by end of 2025 with an 80% customer retention rate, and won the EY Scale Up Award 2025 recognizing its exceptional growth trajectory. Founded in 2015 by Pablo Pazos, Patricia Seoane, Enrique Torres, Álvaro Gutiérrez, and María González; pivoted to AI-first model in 2018. Certified B Corporation.
Apple Watch, $18B+ revenue 2024, 22% global smartwatch market share, 34% US wearables market, 100M+ active users, Series 10 (2024): sleep apnea detection, blood oxygen, ECG, fall detection, watchOS 11, fitness tracking leader
About
Apple Watch was introduced in 2015 as Apple's entry into personal computing worn on the wrist, designed to extend the iPhone experience to the body and provide health and fitness intelligence unavailable from any other consumer device. Apple's mission for the product evolved rapidly from notification delivery to health monitoring, driven by the recognition that continuous, passive measurement of physiological signals could provide clinically meaningful insights at population scale. Its core technology integrates custom Apple silicon, optical heart rate sensors, an electrical heart sensor for ECG, a blood oxygen sensor, and accelerometers within an ultra-compact, water-resistant enclosure running watchOS.\n\nApple Watch Series 10 (2024) introduced sleep apnea detection — a first for any consumer wearable — joining an existing health feature set that includes ECG, irregular heart rhythm notifications, blood oxygen monitoring, crash detection, and fall detection. The Apple Watch platform connects tightly with the Health app and iPhone ecosystem, with third-party app integrations across fitness, medication tracking, mental health, and chronic disease management. Apple Watch serves a broad customer base from fitness-focused consumers to patients with prescribed monitoring needs, supported by FDA clearances on its core health features.\n\nApple Watch generated an estimated $18 billion or more in revenue in 2024, capturing approximately 22% of global smartwatch market share and 34% of the US wearables market, with more than 100 million active users globally. It competes with Samsung Galaxy Watch and Garmin but has no peer in terms of health feature depth, ecosystem integration, and installed base. As regulatory bodies and health systems increasingly recognize wearable-derived data as clinically actionable, Apple Watch's combination of consumer scale and health credibility positions it as the de facto platform for digital health at the consumer level.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.